peanutbutter Posted September 29, 2012 Report Share Posted September 29, 2012 Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease http://bloodjournal.hematologylibrary.org/content/100/2/627.long For the last four years, pb oil has been focused on the CB2 receptor. Many times problem locations within the body will have their CB1 receptor blocked. To get at the problem, you have to get around the blockage. Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.